MoneyWorks4Me

Glenmark Pharmaceuticals informs about press release

27 Jul 2016 Evaluate

Glenmark Pharmaceuticals has informed about a Press Release dated July 27, 2016 titled ‘Glenmark Pharmaceuticals receives ANDA approval for Potassium Chloride Extended-Release Tablets USP, 10 mEq (750 mg) and 20 mEq (1500 mg)’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1752.50
Dr. Reddys Labs. 1180.00
Cipla 1305.00
Lupin 1942.00
Zydus Lifesciences 1115.20
View more..